Karihtala, Peeter. “How to Choose Optimal Adjuvant Therapies for High-Risk Hormone Receptor-Positive, HER2-Negative Breast Cancer After Chemotherapy?”. Acta Oncologica, vol. 64, June 2025, pp. 815-29, doi:10.2340/1651-226X.2025.43645.